Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR, EULAR Approve New Classification Criteria for Primary Sjögren’s Syndrome

Kathy Holliman  |  November 15, 2016

Criteria History & Development
Eleven classification/diagnostic criteria for SS were published between 1965 and 2002, but they were not endorsed by the ACR or EULAR; the AECG criteria have been the most commonly used classification criteria over the past decade. The ACR Classification Criteria for Sjögren’s Syndrome: A Data-Driven, Expert Consensus Approach in the Sjögren’s International Collaborative Clinical Alliance Cohort was considered a significant step forward when published in 2012, with criteria designed for classifying individuals for enrollment in clinical trials. The criteria were developed using the National Institutes of Health-funded Sjögren’s International Collaborative Clinical Alliance (SICCA) registry, and were based on the need for specificity rather than a reliance on symptoms for a diagnosis, such as dry eyes and dry mouth, which can be nonspecific and caused by other conditions. In the 2012 document, the classification criteria of SS required that a patient have at least two of the following objective features:

  • Positive serum anti-SSA and/or anti-SSB or (positive rheumatoid factor and antinuclear antibodies ≥1:320);
  • Ocular staining score ≥3; and
  • Labial salivary gland biopsy exhibiting focal lymphocytic sialadenitis with a focus score of ≥1 foci/4 mm2.

Analyses were subsequently performed in a cohort of patients at the Oklahoma Medical Research Foundation that compared the ACR and AECG criteria. Those analyses found a high level of agreement. Investigators from both the SICCA team and the EULAR Sjögren’s Task Force formed the International Sjögren’s Syndrome Criteria Working Group in 2012, with the primary purpose of developing classification criteria for primary SS that combined features of the ACR and AECG criteria. The 2016 document is the result of that work.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The Time Is Right
The focus on primary SS is consistent with the working group’s goal of producing criteria that will aid in recruitment of patients for clinical trials. The landscape of SS has changed in recent years due to both the recently validated disease activity indices and the availability of new therapeutic agents, Dr. Shiboski says. “The publication of a single set of classification criteria for SS that has the buy-in of the international SS scientific community and has been approved by ACR and EULAR is extremely timely. The pharmaceutical industry has a number of new therapeutic agents waiting to be tested in clinical trials. Further, a universal set of criteria will greatly improve comparison of results across clinical studies. The new criteria set is also in keeping with ACR and EULAR objectives of elaborating and actively promoting, disseminating and implementing ACR and EULAR recommendations and criteria for the most common rheumatic and musculoskeletal diseases.”

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsEducation & TrainingEULAR/OtherMeeting ReportsSjögren’s Disease Tagged with:Classification CriteriaEULARSjogren's

Related Articles
    In Green / shutterstock.com

    Sjögren’s Syndrome in Kids: Diagnostic Challenges & Treatment Options

    January 17, 2020

    A 14-year-old girl is referred to your office for fatigue and arthralgias. While you’re obtaining her past medical history, she divulges that she has had four episodes of bilateral parotitis, each lasting two weeks. An otolaryngologist evaluated her. She lacked sicca symptoms, had a normal complete blood count (CBC), normal inflammatory markers and a negative…

    Systemic Sjögrens: More Than a Sicca Disease

    November 1, 2014

    Differences in its epidemiologic, clinical and immunologic features underscore need for a homogeneous diagnostic and therapeutic approach

    Clinical Guidelines for Sjögren’s Syndrome Focus on Biologics, Fatigue, Inflammatory Musculoskeletal Pain

    June 15, 2017

    The first clinical practice guidelines for Sjögren’s syndrome have been released, the culmination of an initiative by the Sjögren’s Syndrome Foundation.1 These standard-of-care recommendations are intended to provide consistency in practice patterns, inform coverage and reimbursement policies, lead to the design and implementation of educational programs, highlight the needs for future research and fill a…

    Multidisciplinary Guidance for Pulmonary Disease in Sjögren’s Syndrome

    February 2, 2022

    Lung disease is common, variable and frequently underdiagnosed in patients with Sjögren’s syndrome. An expert pulmonologist and a rheumatologist discussed the diagnosis and management of pulmonary manifestations of Sjögren’s syndrome during ACR Convergence 2021.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences